Dr. Lal Pathlabs, 539524, LALPATHLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,060.61
54.69
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

27,221.93
0.72%
12.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.02
9.25
6.86

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.85
9.78
7.27

PAT CAGR (%)

10 Years
5 Years
3 Years

13.93
10.81
26.82

P:E (Median)

8 Years
5 Years
3 Years

61.05
71.55
67.62

P:BV (Average)

8 Years
5 Years
3 Years

12.99
14.34
11.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.73
37.39
32.78

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 43.05 58.27 59.3 69.27
P/E Ratio 77.77 57.45 56.46 48.33
Revenue 2227 2461 2751 3083
EBITDA 609 696 759 860
Net Income 358 487 495 578
ROA 14.8 18.8 18.5 19.1
P/B Ratio 14.66 12.88 11.38 10.01
ROE 20.35 24.22 21.34 21.93
FCFF 500 585 550 635
FCFF Yield 2.21 2.58 2.43 2.8
Net Debt -697 -1008 -1439 -1834
BVPS 228.29 259.92 294.08 334.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 640.70 574.40 11.54% 577.20 520.90 10.81% 528.10 476.00 10.95% 583.90 531.70 9.82%
Expenses 457.30 413.10 10.70% 418.10 383.30 9.08% 382.70 345.90 10.64% 399.40 368.70 8.33%
EBITDA 183.40 161.30 13.70% 159.10 137.60 15.62% 145.40 130.10 11.76% 184.50 163.00 13.19%
EBIDTM 28.62% 28.08% 27.56% 26.42% 27.53% 27.33% 31.60% 30.66%
Other Income 26.30 30.90 -14.89% 25.20 16.50 52.73% 29.50 15.10 95.36% 22.00 14.10 56.03%
Interest 4.50 5.80 -22.41% 4.80 6.30 -23.81% 4.80 6.50 -26.15% 5.00 7.10 -29.58%
Depreciation 32.80 32.70 0.31% 34.60 34.60 0.00% 18.90 19.20 -1.56% 18.20 19.10 -4.71%
PBT 172.40 153.70 12.17% 144.90 113.20 28.00% 151.20 119.50 26.53% 183.30 150.90 21.47%
Tax 43.10 39.20 9.95% -3.50 32.40 - 36.70 31.20 17.63% 48.10 37.90 26.91%
PAT 129.30 114.50 12.93% 148.40 80.80 83.66% 114.50 88.30 29.67% 135.20 113.00 19.65%
PATM 20.18% 19.93% 25.71% 15.51% 21.68% 18.55% 23.15% 21.25%
EPS 15.43 13.66 12.96% 17.71 9.64 83.71% 13.66 10.54 29.60% 16.13 13.48 19.66%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 669.80 601.90 11.28% 602.60 545.40 10.49% 596.70 538.90 10.73% 660.20 601.30 9.80%
Expenses 477.50 431.90 10.56% 433.60 400.70 8.21% 442.70 398.30 11.15% 457.70 423.50 8.08%
EBITDA 192.30 170.00 13.12% 169.00 144.70 16.79% 154.00 140.60 9.53% 202.50 177.80 13.89%
EBIDTM 28.71% 28.24% 28.05% 26.53% 25.81% 26.09% 30.67% 29.57%
Other Income 28.10 20.60 36.41% 25.80 18.40 40.22% 25.10 18.30 37.16% 21.90 18.10 20.99%
Interest 4.70 6.00 -21.67% 5.00 6.60 -24.24% 5.30 7.00 -24.29% 6.00 7.80 -23.08%
Depreciation 34.60 34.70 -0.29% 36.40 36.60 -0.55% 35.50 36.00 -1.39% 35.30 35.90 -1.67%
PBT 181.10 149.90 20.81% 153.40 119.90 27.94% 138.30 115.90 19.33% 183.10 152.20 20.30%
Tax 47.10 42.10 11.88% -2.10 34.10 - 40.20 33.70 19.29% 52.30 41.50 26.02%
PAT 134.00 107.80 24.30% 155.50 85.80 81.24% 98.10 82.20 19.34% 130.80 110.70 18.16%
PATM 20.01% 17.91% 25.80% 15.73% 16.44% 15.25% 19.81% 18.41%
EPS 15.80 12.74 24.02% 18.52 10.12 83.00% 11.57 9.74 18.79% 15.45 13.09 18.03%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,329.90 2,351.61 2,125.06 1,769.03 1,878.79 1,490.56 1,273.60 1,164.90 1,024.04 881.88 765.40 Net Sales Growth 10.79% 10.66% 20.13% -5.84% 26.05% 17.04% 9.33% 13.76% 16.12% 15.22% Cost Of Goods Sold 445.80 455.24 427.87 389.64 447.65 373.90 286.87 254.96 219.31 191.25 168.13 Gross Profit 1,884.10 1,896.38 1,697.19 1,379.39 1,431.14 1,116.65 986.73 909.94 804.73 690.63 597.27 GP Margin 80.87% 80.64% 79.87% 77.97% 76.17% 74.91% 77.48% 78.11% 78.58% 78.31% 78.03% Total Expenditure 1,657.50 1,686.21 1,544.45 1,308.33 1,366.32 1,083.17 945.79 882.10 767.93 651.76 563.62 Power & Fuel Cost - 25.48 24.47 21.31 19.66 17.18 15.65 14.65 14.40 12.85 12.12 % Of Sales - 1.08% 1.15% 1.20% 1.05% 1.15% 1.23% 1.26% 1.41% 1.46% 1.58% Employee Cost - 457.54 402.57 315.50 321.44 257.44 232.06 201.86 175.09 147.31 133.07 % Of Sales - 19.46% 18.94% 17.83% 17.11% 17.27% 18.22% 17.33% 17.10% 16.70% 17.39% Manufacturing Exp. - 459.39 414.28 358.22 343.63 249.34 217.76 190.60 163.72 134.26 18.22 % Of Sales - 19.54% 19.49% 20.25% 18.29% 16.73% 17.10% 16.36% 15.99% 15.22% 2.38% General & Admin Exp. - 240.81 223.37 182.50 188.78 147.14 156.24 182.56 165.73 139.44 210.54 % Of Sales - 10.24% 10.51% 10.32% 10.05% 9.87% 12.27% 15.67% 16.18% 15.81% 27.51% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 47.75 51.89 41.17 45.16 38.18 37.20 37.47 29.68 26.66 0.00 % Of Sales - 2.03% 2.44% 2.33% 2.40% 2.56% 2.92% 3.22% 2.90% 3.02% 2.81% EBITDA 672.40 665.40 580.61 460.70 512.47 407.39 327.81 282.80 256.11 230.12 201.78 EBITDA Margin 28.86% 28.30% 27.32% 26.04% 27.28% 27.33% 25.74% 24.28% 25.01% 26.09% 26.36% Other Income 103.00 111.52 66.30 46.60 53.10 51.27 57.61 46.49 31.51 28.28 22.47 Interest 19.10 21.50 28.60 34.38 28.63 14.82 14.66 0.74 0.82 0.70 0.49 Depreciation 104.50 134.15 135.79 82.09 75.94 69.78 68.01 36.18 31.05 26.44 32.01 PBT 651.80 621.28 482.53 390.83 460.99 374.04 302.75 292.37 255.76 231.26 191.75 Tax 124.40 124.02 135.80 98.47 115.74 93.94 79.57 96.93 87.49 78.78 66.00 Tax Rate 19.09% 19.96% 28.14% 25.20% 25.11% 25.11% 26.28% 33.15% 34.21% 34.07% 34.42% PAT 527.40 497.26 346.73 292.36 345.25 280.11 223.18 195.44 168.27 152.48 125.75 PAT before Minority Interest 527.40 497.26 346.73 292.36 345.25 280.11 223.18 195.44 168.27 152.48 125.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.64% 21.15% 16.32% 16.53% 18.38% 18.79% 17.52% 16.78% 16.43% 17.29% 16.43% PAT Growth 32.98% 43.41% 18.60% -15.32% 23.26% 25.51% 14.19% 16.15% 10.36% 21.26% EPS 62.94 59.34 41.38 34.89 41.20 33.43 26.63 23.32 20.08 18.20 15.01

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,529.30 2,461.39 2,226.64 2,016.88 2,087.41 1,581.27 1,330.36 1,203.42 1,056.92 912.38 791.32 Net Sales Growth 10.57% 10.54% 10.40% -3.38% 32.01% 18.86% 10.55% 13.86% 15.84% 15.30% Cost Of Goods Sold 491.00 481.46 451.42 447.15 502.25 397.26 298.70 262.35 226.03 197.08 172.92 Gross Profit 2,038.30 1,979.93 1,775.22 1,569.73 1,585.16 1,184.01 1,031.65 941.07 830.89 715.30 618.40 GP Margin 80.59% 80.44% 79.73% 77.83% 75.94% 74.88% 77.55% 78.20% 78.61% 78.40% 78.15% Total Expenditure 1,811.50 1,765.80 1,617.40 1,527.05 1,526.68 1,144.99 986.78 909.76 792.92 674.86 583.66 Power & Fuel Cost - 27.16 26.18 25.91 22.11 18.62 16.74 15.74 15.32 13.58 12.78 % Of Sales - 1.10% 1.18% 1.28% 1.06% 1.18% 1.26% 1.31% 1.45% 1.49% 1.62% Employee Cost - 482.36 424.57 376.52 364.94 273.70 242.64 208.29 180.75 152.01 136.83 % Of Sales - 19.60% 19.07% 18.67% 17.48% 17.31% 18.24% 17.31% 17.10% 16.66% 17.29% Manufacturing Exp. - 467.86 423.24 385.55 361.63 257.16 224.87 196.24 166.22 137.24 18.89 % Of Sales - 19.01% 19.01% 19.12% 17.32% 16.26% 16.90% 16.31% 15.73% 15.04% 2.39% General & Admin Exp. - 255.49 236.97 233.04 229.30 157.20 164.31 188.71 174.12 147.72 220.05 % Of Sales - 10.38% 10.64% 11.55% 10.98% 9.94% 12.35% 15.68% 16.47% 16.19% 27.81% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 51.46 55.02 58.88 46.45 41.05 39.51 38.43 30.48 27.23 0.00 % Of Sales - 2.09% 2.47% 2.92% 2.23% 2.60% 2.97% 3.19% 2.88% 2.98% 2.80% EBITDA 717.80 695.59 609.24 489.83 560.73 436.28 343.58 293.66 264.00 237.52 207.66 EBITDA Margin 28.38% 28.26% 27.36% 24.29% 26.86% 27.59% 25.83% 24.40% 24.98% 26.03% 26.24% Other Income 100.90 93.43 69.17 41.72 52.55 51.33 55.05 45.95 31.22 27.54 21.84 Interest 21.00 22.30 29.36 37.53 30.18 16.00 15.31 0.84 0.84 0.70 0.50 Depreciation 141.80 141.92 143.60 150.19 108.11 77.20 72.81 38.22 33.06 27.54 28.28 PBT 655.90 624.80 505.45 343.83 474.98 394.41 310.50 300.55 261.31 236.82 200.72 Tax 137.50 132.55 143.16 102.75 124.69 97.93 82.92 100.08 89.56 81.23 67.49 Tax Rate 20.96% 21.21% 28.32% 29.88% 26.25% 24.83% 26.71% 33.30% 34.27% 34.30% 33.62% PAT 518.40 487.14 357.73 238.85 344.83 291.62 225.94 199.18 170.73 154.59 132.19 PAT before Minority Interest 513.10 492.25 362.29 241.08 350.29 296.48 227.59 200.47 171.75 155.59 133.23 Minority Interest -5.30 -5.11 -4.56 -2.23 -5.46 -4.86 -1.65 -1.29 -1.02 -1.00 -1.04 PAT Margin 20.50% 19.79% 16.07% 11.84% 16.52% 18.44% 16.98% 16.55% 16.15% 16.94% 16.70% PAT Growth 34.13% 36.18% 49.77% -30.73% 18.25% 29.07% 13.44% 16.66% 10.44% 16.95% EPS 61.86 58.13 42.69 28.50 41.15 34.80 26.96 23.77 20.37 18.45 15.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,134.23 1,800.72 1,689.86 1,472.12 1,217.09 1,016.28 930.84 776.52 586.44 479.24 Share Capital 83.59 83.48 83.37 83.34 83.34 83.34 83.34 83.33 83.07 82.68 Total Reserves 1,994.00 1,666.09 1,548.48 1,331.33 1,093.94 900.05 819.45 675.25 494.83 395.84 Non-Current Liabilities 13.75 53.98 165.59 257.40 76.83 68.18 -19.86 -8.46 -6.00 12.07 Secured Loans 0.00 0.00 83.33 166.67 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 388.44 450.47 432.16 451.04 252.25 211.29 134.46 111.12 82.58 88.96 Trade Payables 193.05 180.25 140.16 123.47 135.57 112.75 77.17 62.42 50.62 40.58 Other Current Liabilities 147.92 222.09 198.27 208.51 95.89 83.96 39.70 38.86 25.14 17.41 Short Term Borrowings 0.00 0.00 70.00 95.42 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 47.46 48.13 23.73 23.63 20.78 14.59 17.58 9.84 6.82 30.96 Total Liabilities 2,536.42 2,305.17 2,287.61 2,180.56 1,546.17 1,295.75 1,045.44 879.18 663.02 580.27 Net Block 1,017.83 1,070.70 361.48 370.95 300.07 296.53 172.96 172.53 120.99 129.78 Gross Block 1,740.28 1,666.78 735.64 667.13 520.03 448.96 262.15 226.38 147.43 307.16 Accumulated Depreciation 722.46 596.08 374.16 296.18 219.97 152.43 89.20 53.85 26.44 177.38 Non Current Assets 1,259.14 1,268.78 1,477.45 1,481.24 456.86 433.34 249.20 266.42 207.15 164.20 Capital Work in Progress 3.48 5.65 4.94 14.45 8.99 11.29 2.87 9.36 17.20 4.09 Non Current Investment 113.94 112.94 1,072.03 1,061.81 120.40 93.88 32.37 29.71 31.32 11.59 Long Term Loans & Adv. 22.92 27.92 19.89 24.33 23.87 18.43 16.23 14.61 16.11 15.21 Other Non Current Assets 67.62 17.87 19.11 9.71 3.53 13.21 24.77 40.21 21.54 3.52 Current Assets 1,277.28 1,036.39 810.17 699.31 1,089.30 862.41 796.23 612.76 455.87 416.07 Current Investments 301.70 100.28 141.38 0.00 50.21 158.89 181.67 143.85 102.96 62.59 Inventories 32.27 32.85 23.34 39.84 38.94 55.00 27.81 26.65 17.14 14.08 Sundry Debtors 105.39 87.47 63.32 67.02 63.54 50.25 53.10 40.18 40.26 34.86 Cash & Bank 767.54 751.67 534.22 542.90 888.63 549.19 478.11 306.78 234.72 206.74 Other Current Assets 70.38 45.91 30.89 32.07 47.98 49.07 55.54 95.29 60.79 97.80 Short Term Loans & Adv. 21.22 18.22 17.03 17.48 16.98 20.13 31.61 80.08 48.24 87.91 Net Current Assets 888.85 585.92 378.01 248.28 837.05 651.12 661.77 501.64 373.29 327.12 Total Assets 2,536.42 2,305.17 2,287.62 2,180.55 1,546.16 1,295.75 1,045.43 879.18 663.02 580.27

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,172.72 1,849.28 1,666.30 1,501.61 1,245.06 1,032.81 945.50 787.85 595.52 507.35 Share Capital 83.59 83.48 83.37 83.34 83.34 83.34 83.34 83.33 83.07 82.68 Total Reserves 2,032.48 1,714.65 1,524.67 1,359.98 1,121.91 916.58 834.12 686.58 503.91 423.94 Non-Current Liabilities 21.34 62.16 175.84 272.66 83.01 70.12 -20.25 -8.96 -6.41 12.16 Secured Loans 0.00 0.00 83.33 166.67 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.13 0.12 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.95 1.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 Current Liabilities 402.35 463.58 469.75 499.99 274.29 227.31 138.30 115.96 84.84 90.78 Trade Payables 198.85 186.57 156.10 147.38 144.13 117.73 79.80 65.45 52.38 42.27 Other Current Liabilities 154.51 227.46 214.02 226.98 108.00 94.03 40.58 40.38 25.37 17.55 Short Term Borrowings 0.00 0.00 70.00 95.42 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 48.99 49.55 29.63 30.20 22.16 15.55 17.93 10.13 7.09 30.97 Total Liabilities 2,630.17 2,411.10 2,345.14 2,309.72 1,633.32 1,351.46 1,069.03 898.64 676.39 613.18 Net Block 1,134.99 1,193.83 1,305.06 1,368.81 447.26 413.02 208.66 207.52 152.43 165.64 Gross Block 1,903.54 1,828.44 1,807.22 1,726.23 683.53 574.29 301.66 263.71 180.09 335.80 Accumulated Depreciation 768.55 634.62 502.16 357.42 236.27 161.27 93.00 56.19 27.66 170.16 Non Current Assets 1,266.66 1,284.41 1,372.05 1,434.56 488.14 458.81 255.41 275.61 209.83 189.45 Capital Work in Progress 3.48 5.65 4.94 15.00 9.61 11.38 3.44 9.56 17.51 4.09 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 26.66 31.26 35.21 39.89 27.14 20.38 16.95 16.26 17.79 15.58 Other Non Current Assets 68.18 19.97 26.84 10.86 4.13 14.03 26.36 42.27 22.09 4.13 Current Assets 1,363.51 1,126.70 973.09 875.15 1,145.17 892.65 813.63 623.02 466.56 423.74 Current Investments 326.70 113.78 149.94 65.46 59.30 164.28 184.78 144.80 106.08 64.32 Inventories 36.13 37.31 33.81 52.54 42.56 56.96 28.54 27.34 17.91 14.52 Sundry Debtors 88.12 77.40 70.82 85.39 66.70 51.39 53.22 41.16 41.80 36.31 Cash & Bank 838.68 830.31 665.41 617.59 926.03 569.12 490.24 313.51 239.51 209.95 Other Current Assets 73.88 47.89 34.38 33.83 50.58 50.91 56.85 96.22 61.25 98.64 Short Term Loans & Adv. 23.00 20.01 18.72 20.34 18.82 21.38 32.46 80.76 48.55 88.60 Net Current Assets 961.16 663.12 503.33 375.16 870.88 665.34 675.33 507.06 381.72 332.95 Total Assets 2,630.17 2,411.11 2,345.14 2,309.71 1,633.31 1,351.46 1,069.04 898.63 676.39 613.19

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 540.00 504.60 427.53 425.73 373.36 271.99 208.50 189.38 166.67 142.25 PBT 621.28 482.53 390.83 460.99 374.04 302.75 292.37 255.76 152.48 191.75 Adjustment 74.79 120.22 96.31 87.81 59.10 45.84 8.85 17.30 90.08 11.02 Changes in Working Capital -1.44 29.67 39.52 -5.55 37.33 12.57 9.66 7.86 -7.91 6.22 Cash after chg. in Working capital 694.63 632.42 526.66 543.25 470.47 361.15 310.88 280.92 234.65 208.99 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -154.63 -127.82 -99.13 -117.53 -97.12 -89.17 -102.38 -91.53 -67.98 -66.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -293.00 1.17 -288.47 -448.53 -195.19 -19.47 -92.75 -165.90 -134.49 -148.14 Net Fixed Assets -71.33 -931.85 -59.00 -152.56 -68.77 -195.23 -29.28 -71.11 146.62 -43.19 Net Investments -202.42 1,000.19 -151.60 -891.20 82.16 -38.73 -40.48 -39.28 -60.10 -24.82 Others -19.25 -67.17 -77.87 595.23 -208.58 214.49 -22.99 -55.51 -221.01 -80.13 Cash from Financing Activity -324.75 -410.53 -270.05 141.24 -135.74 -187.22 -54.33 12.93 -31.59 0.99 Net Cash Inflow / Outflow -77.75 95.24 -130.99 118.43 42.42 65.30 61.43 36.41 0.59 -4.89 Opening Cash & Equivalents 344.34 249.10 351.31 232.87 189.24 123.95 62.52 26.11 25.38 22.95 Closing Cash & Equivalent 266.60 344.34 220.32 351.31 231.66 189.24 123.95 62.52 25.97 18.06

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 568.88 535.33 456.03 446.69 398.15 283.89 218.54 197.06 171.31 158.54 PBT 624.80 505.45 343.83 474.98 394.41 310.50 300.55 261.31 155.59 200.72 Adjustment 101.97 126.18 183.16 118.45 68.77 54.69 12.96 20.86 94.46 7.98 Changes in Working Capital 6.01 35.74 35.48 -16.71 36.67 12.17 9.30 8.93 -8.13 18.55 Cash after chg. in Working capital 732.78 667.37 562.46 576.72 499.85 377.36 322.81 291.10 241.92 227.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -163.90 -132.03 -106.43 -130.03 -101.70 -93.47 -104.28 -94.03 -70.61 -68.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -303.16 -24.27 -287.31 -449.25 -212.02 -26.11 -99.74 -172.28 -137.11 -163.49 Net Fixed Assets -71.33 -931.85 -59.00 -152.56 -68.77 -195.23 -29.28 -71.11 146.62 -43.19 Net Investments -202.42 1,000.19 -151.60 -891.20 82.16 -38.73 -40.48 -39.28 -60.10 -24.82 Others -29.41 -92.61 -76.71 594.51 -225.41 207.85 -29.98 -61.89 -223.63 -95.48 Cash from Financing Activity -334.03 -413.86 -283.18 136.45 -138.56 -190.44 -55.26 12.51 -32.26 0.36 Net Cash Inflow / Outflow -68.31 97.20 -114.46 133.90 47.58 67.33 63.54 37.30 1.94 -4.59 Opening Cash & Equivalents 360.93 263.73 378.19 244.30 196.72 129.39 65.85 28.55 26.61 23.28 Closing Cash & Equivalent 292.63 360.93 263.73 378.20 244.30 196.72 129.39 65.85 28.55 18.70

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 248.54 209.58 195.74 169.74 141.25 117.99 108.32 91.03 69.57 57.88 ROA 20.54% 15.10% 13.09% 18.53% 19.71% 19.07% 20.31% 21.82% 24.53% 25.04% ROE 25.99% 20.51% 19.19% 26.64% 25.93% 23.66% 23.53% 25.18% 28.87% 32.62% ROCE 31.99% 26.83% 22.71% 32.27% 34.82% 32.60% 34.34% 37.65% 43.53% 48.15% Fixed Asset Turnover 1.38 1.77 2.52 3.17 3.08 3.58 4.77 5.48 3.88 2.67 Receivable days 14.97 12.95 13.45 12.68 13.93 14.81 14.61 14.33 15.54 15.33 Inventory Days 5.05 4.83 6.52 7.65 11.50 11.87 8.53 7.80 6.46 6.63 Payable days 149.65 136.66 123.48 105.61 121.20 41.95 36.22 33.95 32.28 36.58 Cash Conversion Cycle -129.63 -118.89 -103.52 -85.28 -95.77 -15.28 -13.08 -11.82 -10.28 -14.62 Total Debt/Equity 0.00 0.05 0.14 0.24 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 29.90 17.87 12.37 17.10 26.23 21.65 394.50 314.05 332.31 392.68

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 253.14 215.40 192.88 173.17 144.61 119.97 110.08 92.39 70.66 61.28 ROA 19.53% 15.23% 10.36% 17.77% 19.87% 18.81% 20.38% 21.81% 24.13% 25.06% ROE 25.15% 21.27% 15.80% 26.45% 26.89% 23.74% 23.76% 25.32% 28.45% 32.45% ROCE 31.53% 27.89% 20.34% 32.67% 36.03% 32.94% 34.78% 37.90% 43.07% 47.43% Fixed Asset Turnover 1.32 1.22 1.14 1.73 2.51 3.04 4.26 4.76 3.54 2.51 Receivable days 12.27 12.15 14.14 13.30 13.63 14.35 14.31 14.32 15.62 15.51 Inventory Days 5.45 5.83 7.81 8.31 11.49 11.73 8.47 7.81 6.49 6.64 Payable days 146.09 138.53 123.86 105.92 120.30 41.84 36.52 34.38 32.53 37.45 Cash Conversion Cycle -128.38 -120.56 -101.91 -84.31 -95.18 -15.76 -13.73 -12.25 -10.42 -15.30 Total Debt/Equity 0.00 0.05 0.15 0.24 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 29.01 18.22 10.16 16.74 25.65 21.28 359.22 311.72 340.29 404.57

Top Investors:

hdfc trustee company limited-hdfc flexi cap fund

invesco oppenheimer international growth fund

uti-flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

sbi large & midcap fund

smallcap world fund, inc

life insurance corporation of india

the brown capital management international small company fund

sundaram mutual fund a/c sundaram mid cap fund

indus india fund (mauritius) limited

Annual Reports:

News Update:

Dr. Lal PathLabs expands genomics capabilities with Illumina's NovaSeq X Series
25th Jun 2025, 14:42 PM

With the integration of Illumina’s latest technology, the company can now deliver faster and more accurate genomic research insights
Read More

Dr. Lal Pathlabs Ltd.

Healthcare Services - Diagnostic

BSE: 539524 | NSE: LALPATHLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Dr. Lal Pathlabs Ltd.

Healthcare Services - Diagnostic

BSE: 539524 | NSE: LALPATHLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: